Cystic Fibrosis Screening

It is a highly multiplexed panel for screening clinically significant 72 common mutations in the CFTR gene. This panel also includes 5T variant which is a common mild variant occurring in 1 in 10 individuals in the general population.

Please Contact us for more details.

What it screens?
What it screens?

It is an investigation performed during pregnancy in the second trimester to classify a patient as either high-risk or low-risk for chromosomal abnormalities (and neural tube defects).


The below table shows a list of 72 common CFTR mutationsincluded in the Panel in which 23 are ACMG/ACOG recommended mutations and the other 49 are the most common variants with known relevance.

Who should be screened ?
Who should be screened ?

Patients with positive sweat test results. Infant or child presenting with symptoms like diarrhea, malnutrition, poor growth, and weight loss.


  • Individuals with symptoms like chronic coughing, wheezing, and inflammation
  • Abnormal prenatal ultrasound findings (like hyperechogenic fetal bowel) during routine pregnancy tests.
  • Any carrier or CF affected individual in family.
  • Male Parent presentingsymptoms of infertility.
  • Couples who are married within family

Complete insight into your health today, bridged with the answers for Tomorrow


FREE Sample Collection

PAN India Logistics

Accurate Reporting

Fast TAT

Stringent QC